ArticleCell death & disease2020

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma.

Ishani Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.